scispace - formally typeset
M

Mingquan Zheng

Researcher at University of Pittsburgh

Publications -  38
Citations -  4874

Mingquan Zheng is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Immune system & Antigen. The author has an hindex of 25, co-authored 38 publications receiving 4574 citations. Previous affiliations of Mingquan Zheng include Boston Children's Hospital & LSU Health Sciences Center New Orleans.

Papers
More filters
Journal ArticleDOI

IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia

TL;DR: Although both cytokines regulated CXC chemokines and granulocyte colony–stimulating factor production in the lung, only IL-22 increased lung epithelial cell proliferation and increased transepithelial resistance to injury, and data support the concept that the TH17 cell lineage and its effector molecules have evolved to effect host defense against extracellular pathogens at mucosal sites.
Journal ArticleDOI

Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae

TL;DR: Independent requirements for IL-12 and IL-23 in pulmonary host defense against K. pneumoniae are demonstrated, the former of which is required for IFN-γ expression and the latter of which has been required forIL-17 production.
Journal ArticleDOI

Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection.

TL;DR: It is shown in vivo that intact Toll-like receptor 4 signaling in the lung is required for induction of both the p19 transcript of IL-23 and IL-17 protein elaboration in response to Klebsiella pneumoniae, and a direct role for IL- 23 is suggested in CD8+ T cell IL- 17 production.
Journal ArticleDOI

Critical role of IL-17 receptor signaling in acute TNBS-induced colitis.

TL;DR: It is demonstrated that IL‐17R signaling plays a critical role in the development of TNBS‐induced colitis and may represent a target for therapeutic intervention for IBD.
Journal ArticleDOI

Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3.

TL;DR: Chronic‐binge ethanol feeding may be a useful model to study the early stages of alcoholic liver injury and IL‐22 treatment could be a potential therapeutic option to ameliorate alcoholic liver disease, due to its antioxidant, antiapoptotic, antisteatotic, proliferative, and antimicrobial effects with the added benefit of potentially few side effects.